SCHEMBL629884

SCHEMBL629884

CC(=O)OCCc1cc[nH]n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.38
TSHR P16473 1/20 0.38
RAD52 P43351 1/20 0.38
PDE3B Q13370 3/20 0.37
PDE3A Q14432 3/20 0.37
P2RY12 Q9H244 3/20 0.37
HTT P42858 1/20 0.36
CHRM5 P08912 2/20 0.34
CHRM1 P11229 2/20 0.34
CHRM3 P20309 2/20 0.34
PGR P06401 1/20 0.34
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
HTR1A P08908 1/20 0.34
CHRNB2 P17787 1/20 0.34
TBXA2R P21731 1/20 0.34
CHRNB4 P30926 1/20 0.34
CHRNA3 P32297 1/20 0.34
CHRNA7 P36544 1/20 0.34
CHRNA4 P43681 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27405932 0.83 HTT (0.39) ALDH1A1HTTSMN1; SMN2MEN1CYP1A2
SCHEMBL22412894 0.81 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2CYP1A2CYP3A4
SCHEMBL30505617 0.78 ALDH1A1 (0.42) ALDH1A1TSHRPDE3BPDE3AP2RY12
Betazole SCHEMBL2891008 0.75 AOC3 (0.33) TSHRHTR1ASMN1; SMN2
SCHEMBL24690840 0.73
SCHEMBL7697974 0.72 KEAP1 (0.42) ALDH1A1CHRM1L3MBTL1CYP1A2
SCHEMBL2633369 0.71 ALDH1A1 (0.43) ALDH1A1TSHRHTTSMN1; SMN2KMT2A
SCHEMBL24015848 0.71 MTNR1A (0.44) SMN1; SMN2L3MBTL1
Hydrochloric Acid SCHEMBL17361360 0.71
SCHEMBL2561694 0.70 CAPN1 (0.46) ALDH1A1PDE3BPDE3AP2RY12SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104663674-B Fungicide compound and mixture 杜邦公司 2017-11-03 CN disclosed
EP-1534680-B1 PRENYLATION INHIBITORS AND METHODS OF THEIR SYNTHESIS AND USE PHARMACO INVESTMENTS INC (US) 2012-02-22 EP disclosed
US-7501446-B2 Prenylation inhibitors and methods of their synthesis and use PPD DISCOVERY, INC. (US) 2009-03-10 US disclosed
US-20080119524-A1 PRENYLATION INHIBITORS CONTAINING DIMETHYLCYCLOBUTANE AND METHODS OF THEIR SYNTHESIS AND USE PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. 2008-05-22 US disclosed
US-20070149549-A1 3-(Pyrid-3-yl)-5-(thiophen-2-yl)-pyrazoles; prenyl-protein transferase inhibitors PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC 2007-06-28 US disclosed
US-7166619-B2 Prenylation inhibitors and methods of their synthesis and use PPD DISCOVERY , INC. (US) 2007-01-23 US disclosed
EP-1534279-A4 PRENYLATION INHIBITORS CONTAINING DIMETHYL-CYCLOBUTANE AND METHODS OF THEIR SYNTHESIS AND USE PPD DISCOVERY INC (US) 2006-11-08 EP disclosed
EP-1534680-A4 PRENYLATION INHIBITORS AND METHODS OF THEIR SYNTHESIS AND USE PPD DISCOVERY INC (US) 2006-06-07 EP disclosed
EP-1534279-A2 PRENYLATION INHIBITORS CONTAINING DIMETHYL-CYCLOBUTANE AND METHODS OF THEIR SYNTHESIS AND USE PPD DISCOVERY, INC. (US) 2005-06-01 EP disclosed
EP-1534680-A1 PRENYLATION INHIBITORS AND METHODS OF THEIR SYNTHESIS AND USE PPD DISCOVERY, INC. (US) 2005-06-01 EP disclosed
US-20050004122-A1 Prenylation inhibitors containing dimethylcyclobutane and methods of their synthesis and use DEVELOPMENT PARTNERS, LLC 2005-01-06 US disclosed
US-20040116425-A1 Prenylation inhibitors and methods of their synthesis and use X-CHEM, INC. 2004-06-17 US disclosed
WO-2004016741-A2 PRENYLATION INHIBITORS CONTAINING DIMETHYL-CYCLOBUTANE AND METHODS OF THEIR SYNTHESIS AND USE PPD DISCOVERY, INC. (US) 2004-02-26 WO disclosed
WO-2004016592-A1 PRENYLATION INHIBITORS AND METHODS OF THEIR SYNTHESIS AND USE PPD DISCOVERY, INC. (US) 2004-02-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004122-A1 Prenylation inhibitors containing dimethylcyclobutane and methods of their synthesis and use RCE1, GGPS1, FNTA ALDH1A1 3846/4885TSHR 4370/4885RAD52 3843/4885
US-20070149549-A1 3-(Pyrid-3-yl)-5-(thiophen-2-yl)-pyrazoles; prenyl-protein transferase inhibitors FNTA, PTAR1, ZMPSTE24 ALDH1A1 3452/4885TSHR 3501/4885RAD52 4411/4885
US-20080119524-A1 PRENYLATION INHIBITORS CONTAINING DIMETHYLCYCLOBUTANE AND METHODS OF THEIR SYNTHESIS AND USE RCE1, GGPS1, FNTA ALDH1A1 3846/4885TSHR 4370/4885RAD52 3843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.